Baidu
map

Pan Afr Med J:在治疗五岁以下儿童的发烧方面,布洛芬与扑热息痛更有效

2021-05-16 MedSci原创 MedSci原创

大多数儿童疾病都伴有发烧症状,常用的退烧药是布洛芬和扑热息痛。大多数关于布洛芬和扑热息痛治疗五岁以下儿童发烧的有效性的研究是在欧洲和北美进行的,在非洲儿童中进行的研究非常少。近日,研究人员在尼日利亚卡

大多数儿童疾病都伴有发烧症状,常用的退烧药是布洛芬和扑热息痛。大多数关于布洛芬和扑热息痛治疗五岁以下儿童发烧的有效性的研究是在欧洲和北美进行的,在非洲儿童中进行的研究非常少。近日,研究人员在尼日利亚卡拉巴尔大学教学医院进行了一项随机、对照的临床试验,旨在评估布洛芬与扑热息痛在尼日利亚治疗儿童发烧的单剂量疗法的有效性和安全性,研究结果已发表于Pan Afr Med J。

研究共招募了140名符合条件的6-59个月大的儿童,耳温为38℃-40℃,随机接受单剂量布洛芬(10mg/kg)和扑热息痛(15mg/kg)。用药后,儿童入院并在医院观察6小时,在此期间每半小时测量体温并监测不良事件。

 

结果显示,与扑热息痛相比,布洛芬的退烧效果更好。给药1.5-2.5小时后,布洛芬组与扑热息痛组的发热儿童比例存在显著差异(P=0.04)。两种药物的不良反应都很温和,且相似,最常见的不良反应是呕吐。

综上所述,该研究结果表明,与扑热息痛相比,布洛芬在治疗五岁以下儿童的发烧方面更为有效。两种药物的不良反应都很轻微。

 

原始出处:

 

Ekaete Olajide Alaje, et al., Ibuprofen versus paracetamol for treating fever in preschool children in Nigeria: a randomized clinical trial of effectiveness and safety. Pan Afr Med J. 2020 Aug 26;36:350. doi: 10.11604/pamj.2020.36.350.21393.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1715983, encodeId=84601e159833b, content=<a href='/topic/show?id=3f5f54610fe' target=_blank style='color:#2F92EE;'>#扑热息痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54610, encryptionId=3f5f54610fe, topicName=扑热息痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=810132108698, createdName=shenxlcyp, createdTime=Tue Nov 16 15:48:14 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376901, encodeId=2ef113e690127, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611049, encodeId=42dc161104976, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966146, encodeId=3ab99661460f, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caa55135459, createdName=14665664m21暂无昵称, createdTime=Mon May 17 06:50:53 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966140, encodeId=1b4a966140e6, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/d776fb0de4964edb8c8a81cffc82be49/f82fb8b5fd4b491796821dbf06ac64d5.jpg, createdBy=7fc12544791, createdName=1252be95m13暂无昵称, createdTime=Mon May 17 06:06:30 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966020, encodeId=95c49660203d, content=厉害哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/e73685a5383442939a2d18dc47c949e5/7aafee808c2a4e8da0560d59a8d0f7f9.jpg, createdBy=486c5461851, createdName=ms7000000237912293, createdTime=Sun May 16 13:46:53 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1715983, encodeId=84601e159833b, content=<a href='/topic/show?id=3f5f54610fe' target=_blank style='color:#2F92EE;'>#扑热息痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54610, encryptionId=3f5f54610fe, topicName=扑热息痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=810132108698, createdName=shenxlcyp, createdTime=Tue Nov 16 15:48:14 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376901, encodeId=2ef113e690127, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611049, encodeId=42dc161104976, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966146, encodeId=3ab99661460f, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caa55135459, createdName=14665664m21暂无昵称, createdTime=Mon May 17 06:50:53 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966140, encodeId=1b4a966140e6, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/d776fb0de4964edb8c8a81cffc82be49/f82fb8b5fd4b491796821dbf06ac64d5.jpg, createdBy=7fc12544791, createdName=1252be95m13暂无昵称, createdTime=Mon May 17 06:06:30 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966020, encodeId=95c49660203d, content=厉害哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/e73685a5383442939a2d18dc47c949e5/7aafee808c2a4e8da0560d59a8d0f7f9.jpg, createdBy=486c5461851, createdName=ms7000000237912293, createdTime=Sun May 16 13:46:53 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
    2021-05-18 ssnine
  3. [GetPortalCommentsPageByObjectIdResponse(id=1715983, encodeId=84601e159833b, content=<a href='/topic/show?id=3f5f54610fe' target=_blank style='color:#2F92EE;'>#扑热息痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54610, encryptionId=3f5f54610fe, topicName=扑热息痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=810132108698, createdName=shenxlcyp, createdTime=Tue Nov 16 15:48:14 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376901, encodeId=2ef113e690127, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611049, encodeId=42dc161104976, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966146, encodeId=3ab99661460f, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caa55135459, createdName=14665664m21暂无昵称, createdTime=Mon May 17 06:50:53 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966140, encodeId=1b4a966140e6, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/d776fb0de4964edb8c8a81cffc82be49/f82fb8b5fd4b491796821dbf06ac64d5.jpg, createdBy=7fc12544791, createdName=1252be95m13暂无昵称, createdTime=Mon May 17 06:06:30 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966020, encodeId=95c49660203d, content=厉害哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/e73685a5383442939a2d18dc47c949e5/7aafee808c2a4e8da0560d59a8d0f7f9.jpg, createdBy=486c5461851, createdName=ms7000000237912293, createdTime=Sun May 16 13:46:53 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
    2021-05-18 智慧医人
  4. [GetPortalCommentsPageByObjectIdResponse(id=1715983, encodeId=84601e159833b, content=<a href='/topic/show?id=3f5f54610fe' target=_blank style='color:#2F92EE;'>#扑热息痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54610, encryptionId=3f5f54610fe, topicName=扑热息痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=810132108698, createdName=shenxlcyp, createdTime=Tue Nov 16 15:48:14 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376901, encodeId=2ef113e690127, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611049, encodeId=42dc161104976, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966146, encodeId=3ab99661460f, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caa55135459, createdName=14665664m21暂无昵称, createdTime=Mon May 17 06:50:53 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966140, encodeId=1b4a966140e6, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/d776fb0de4964edb8c8a81cffc82be49/f82fb8b5fd4b491796821dbf06ac64d5.jpg, createdBy=7fc12544791, createdName=1252be95m13暂无昵称, createdTime=Mon May 17 06:06:30 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966020, encodeId=95c49660203d, content=厉害哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/e73685a5383442939a2d18dc47c949e5/7aafee808c2a4e8da0560d59a8d0f7f9.jpg, createdBy=486c5461851, createdName=ms7000000237912293, createdTime=Sun May 16 13:46:53 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
    2021-05-17 14665664m21暂无昵称

    有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1715983, encodeId=84601e159833b, content=<a href='/topic/show?id=3f5f54610fe' target=_blank style='color:#2F92EE;'>#扑热息痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54610, encryptionId=3f5f54610fe, topicName=扑热息痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=810132108698, createdName=shenxlcyp, createdTime=Tue Nov 16 15:48:14 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376901, encodeId=2ef113e690127, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611049, encodeId=42dc161104976, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966146, encodeId=3ab99661460f, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caa55135459, createdName=14665664m21暂无昵称, createdTime=Mon May 17 06:50:53 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966140, encodeId=1b4a966140e6, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/d776fb0de4964edb8c8a81cffc82be49/f82fb8b5fd4b491796821dbf06ac64d5.jpg, createdBy=7fc12544791, createdName=1252be95m13暂无昵称, createdTime=Mon May 17 06:06:30 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966020, encodeId=95c49660203d, content=厉害哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/e73685a5383442939a2d18dc47c949e5/7aafee808c2a4e8da0560d59a8d0f7f9.jpg, createdBy=486c5461851, createdName=ms7000000237912293, createdTime=Sun May 16 13:46:53 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
    2021-05-17 1252be95m13暂无昵称

    很好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1715983, encodeId=84601e159833b, content=<a href='/topic/show?id=3f5f54610fe' target=_blank style='color:#2F92EE;'>#扑热息痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54610, encryptionId=3f5f54610fe, topicName=扑热息痛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=810132108698, createdName=shenxlcyp, createdTime=Tue Nov 16 15:48:14 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376901, encodeId=2ef113e690127, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611049, encodeId=42dc161104976, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue May 18 02:48:14 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966146, encodeId=3ab99661460f, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caa55135459, createdName=14665664m21暂无昵称, createdTime=Mon May 17 06:50:53 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966140, encodeId=1b4a966140e6, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/d776fb0de4964edb8c8a81cffc82be49/f82fb8b5fd4b491796821dbf06ac64d5.jpg, createdBy=7fc12544791, createdName=1252be95m13暂无昵称, createdTime=Mon May 17 06:06:30 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966020, encodeId=95c49660203d, content=厉害哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210508/e73685a5383442939a2d18dc47c949e5/7aafee808c2a4e8da0560d59a8d0f7f9.jpg, createdBy=486c5461851, createdName=ms7000000237912293, createdTime=Sun May 16 13:46:53 CST 2021, time=2021-05-16, status=1, ipAttribution=)]
    2021-05-16 ms7000000237912293

    厉害哦

    0

相关资讯

JAMA Pediatr:布洛芬对持续性动脉导管未闭早产儿支气管肺发育不良风险的影响

总体上,布洛芬在降低持续性动脉导管未闭早产儿支气管肺发育不良和死亡率方面无显著优势,但对于23-26周早产儿布洛芬治疗具有一定的效果。

J Endod:体内评估术前布洛芬对不可逆牙髓炎促炎症因子的影响

这篇研究的目的是为了比较罹患不可逆牙髓炎患者术前给予布洛芬后牙髓中促炎症因子的水平与未给予药物患者之间的差异。

J Matern Fetal Neonatal Med:口服扑热息痛VS口服布洛芬治疗早产儿动脉导管未闭的疗效和安全性

本研究旨在评价口服扑热息痛与口服布洛芬治疗早产儿动脉导管未闭(hsPDA)的疗效和安全性,研究结果已在线发表于J Matern Fetal Neonatal Med。

J Oral Maxillofac Surg:预先使用布洛芬 第三磨牙拔除术后疼痛减轻

土耳其一项研究表明,布洛芬的预先使用可使第三磨牙拔除术后第一个24小时内疼痛减轻且补救镇痛需求减少。该论文2019年4月24日在线发表于《口腔颌面外科学杂志》(J Oral Maxillofac Surg)。

​ 布洛芬退烧会致残进入“科学”流言榜

无线耳机致癌?吃香椿会中毒?孩子用布洛芬退烧会致残?近日,由北京市科协、北京市网信办、首都互联网协会指导,北京科技记者编辑协会、北京地区网站联合辟谣平台共同发布4月“科学”流言榜,对近期流传在民间和网络上的9条流言进行科学辟谣。流言一:超级真菌被美国列为“紧急威胁”,中国已有18例确认感染,传染性极强。真相:流言中的“超级真菌”,其学名为耳念珠菌,是一种可以引起严重感染的真菌。目前耳念珠菌在国际上

中国超过5万名儿童研究,布洛芬可显著增加急性肾损伤风险!

布洛芬是一种非甾体类抗炎药(NSAID),是一种非选择性的环氧合酶阻滞剂。

Baidu
map
Baidu
map
Baidu
map